Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Besse

Showing results (71-80 of 511) with videos related to

Pageof 52
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 23, 2015
Crizotinib Improves Osteoarthritis Symptoms in a ROS1-Fusion Advanced Non-Small Cell Lung Cancer PatientJordi Remon, Anas Gazzah, Benjamin Besse, et al.
Bulletin Du Cancer|November 6, 2007
[Targeting epidermal growth factor receptor in non-small cell lung cancer: current advances and perspectives]Antoine Italiano, Benjamin Besse, David Planchard, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 2, 2016
KRAS oncogene in lung cancer: focus on molecularly driven clinical trialsEmmanuelle Kempf, Benoît Rousseau, Benjamin Besse, et al.
The European Respiratory Journal|December 2, 2015
Circulating free DNA, new dynamic marker in nonsmall cell lung cancer patients?Jordi Remon, Julie Gorham, Benjamin Besse, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2008
Leptomeningeal and medullary response to second-line erlotinib in lung adenocarcinomaMathilde Wagner, Benjamin Besse, Corinne Balleyguier, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 27, 2014
LDK378 compassionate use for treating carcinomatous meningitis in an ALK translocated non-small-cell lung cancerJennifer Arrondeau, Samy Ammari, Benjamin Besse, et al.
Cancer Discovery|November 2, 2021
New Immunotherapy Combinations Enter the Battlefield of Malignant MesotheliomaMihaela Aldea, Jose Carlos Benitez, Nathalie Chaput, et al.
Clinical Lung Cancer|November 23, 2021
PD-1 iNhibitor and chemotherapy with concurrent IRradiation at VAried tumor sites in advanced Non-small cell lung cAncer: the Prospective Randomized Phase 3 NIRVANA-Lung TrialJérôme Doyen, Benjamin Besse, Matthieu Texier, et al.
Translational Lung Cancer Research|July 23, 2021
Is there any opportunity for immune checkpoint inhibitor therapy in non-small cell lung cancer patients with brain metastases?Lizza E L Hendriks, Jordi Remon, Jessica Menis, et al.
Nature|February 12, 2024
Forget lung, breast or prostate cancer: why tumour naming needs to changeFabrice André, Elie Rassy, Aurélien Marabelle, et al.
Pageof 52

Showing results (71-80 of 511) with videos related to

Sort By:
Pageof 52
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 23, 2015
Crizotinib Improves Osteoarthritis Symptoms in a ROS1-Fusion Advanced Non-Small Cell Lung Cancer PatientJordi Remon, Anas Gazzah, Benjamin Besse, et al.
Bulletin Du Cancer|November 6, 2007
[Targeting epidermal growth factor receptor in non-small cell lung cancer: current advances and perspectives]Antoine Italiano, Benjamin Besse, David Planchard, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 2, 2016
KRAS oncogene in lung cancer: focus on molecularly driven clinical trialsEmmanuelle Kempf, Benoît Rousseau, Benjamin Besse, et al.
The European Respiratory Journal|December 2, 2015
Circulating free DNA, new dynamic marker in nonsmall cell lung cancer patients?Jordi Remon, Julie Gorham, Benjamin Besse, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2008
Leptomeningeal and medullary response to second-line erlotinib in lung adenocarcinomaMathilde Wagner, Benjamin Besse, Corinne Balleyguier, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 27, 2014
LDK378 compassionate use for treating carcinomatous meningitis in an ALK translocated non-small-cell lung cancerJennifer Arrondeau, Samy Ammari, Benjamin Besse, et al.
Cancer Discovery|November 2, 2021
New Immunotherapy Combinations Enter the Battlefield of Malignant MesotheliomaMihaela Aldea, Jose Carlos Benitez, Nathalie Chaput, et al.
Clinical Lung Cancer|November 23, 2021
PD-1 iNhibitor and chemotherapy with concurrent IRradiation at VAried tumor sites in advanced Non-small cell lung cAncer: the Prospective Randomized Phase 3 NIRVANA-Lung TrialJérôme Doyen, Benjamin Besse, Matthieu Texier, et al.
Translational Lung Cancer Research|July 23, 2021
Is there any opportunity for immune checkpoint inhibitor therapy in non-small cell lung cancer patients with brain metastases?Lizza E L Hendriks, Jordi Remon, Jessica Menis, et al.
Nature|February 12, 2024
Forget lung, breast or prostate cancer: why tumour naming needs to changeFabrice André, Elie Rassy, Aurélien Marabelle, et al.
Pageof 52